Mercedes Gutiérrez Smith is the CEO of Timser Group and one of the leading voices in women’s health innovation in Mexico. She spearheaded the development of Preventix, a non-invasive blood-based test for the early detection of cervical cancer, recognized by Tech4Eva and Líderes Mexicanos as one of the most impactful innovations in healthcare. Since 2018, she has also served as CEO of ATSO Pharma. Mercedes holds an MBA from IPADE and a Master’s degree in Political Science. She is a frequent speaker at international forums such as the Women Economic Forum, Decididas Summit, and Medical Device Day, where she advocates for prevention and equitable access to medical technologies. In her role, she has signed strategic agreements with UN Women and has been recognized globally, receiving awards such as the Mexican Intellectual Property Award, the 2025 Mira Hormone Innovation Award for Innovation of the Year, and being named a finalist for both the WIPO Global Awards and the HER International Awards. Mercedes is also a proud mother of four, balancing her professional mission with a deep personal commitment to empowering women through science and innovation.